Edition:
United States

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613.SS)

600613.SS on Shanghai Stock Exchange

8.48CNY
13 Dec 2017
Change (% chg)

¥0.09 (+1.07%)
Prev Close
¥8.39
Open
¥8.40
Day's High
¥8.48
Day's Low
¥8.36
Volume
1,023,539
Avg. Vol
3,124,479
52-wk High
¥16.45
52-wk Low
¥8.09

Chart for

About

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of... (more)
No analyst recommendations are available for .

Overall

Beta: 0.80
Market Cap(Mil.): ¥4,429.83
Shares Outstanding(Mil.): 534.07
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.96 15.25
EPS (TTM): -- -- --
ROI: -- 15.07 33.27
ROE: -- 16.58 16.35

BRIEF-Shanghai Shenqi Pharmaceutical Investment Management unit passes review of high-tech enterprise recognition

Dec 13Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

4:44am EST

BRIEF-Shanghai Shenqi Pharmaceutical Investment Management adopts new accounting policy regarding subsidy

Aug 29 Shanghai Shenqi Pharmaceutical Investment Management Co Ltd :

Aug 29 2017

BRIEF-Shanghai Shenqi Pharma elects chairman

June 16 Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

Jun 16 2017

Earnings vs. Estimates